A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects With Acute Pain Following Bunionectomy
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness (level of pain control) and safety
of the administration of Extended-Release Hydrocodone/Acetaminophen compared to placebo over
a 48 hour dosing period in patients who have had bunionectomy surgery and to assess the
safety of the drug for 7 days after patients are discharged from the hospital.
Phase:
Phase 3
Details
Lead Sponsor:
Abbott
Treatments:
Acetaminophen Acetaminophen, hydrocodone drug combination Hydrocodone Oxycodone Polystyrene sulfonic acid